Park Jun-Bom, Prodduturi Suneela, Morott Joe, Kulkarni Vijay I, Jacob Melissa R, Khan Shabana I, Stodghill Steven P, Repka Michael A
The University of Mississippi, School of Pharmacy, Department of Pharmaceutics and Drug Delivery , University, MS 38677 , USA.
Expert Opin Drug Deliv. 2015 Jan;12(1):1-13. doi: 10.1517/17425247.2014.949235. Epub 2014 Aug 29.
The overall goal of this research was to produce a stable hot-melt extruded 'Antifungal Denture Adhesive film' (ADA) system for the treatment of oral candidiasis.
The ADA systems with hydroxypropyl cellulose (HPC) and/or polyethylene oxide (PEO) containing clotrimazole (10%) or nystatin (10%) were extruded utilizing a lab scale twin-screw hot-melt extruder. Rolls of the antifungal-containing films were collected and subsequently die-cut into shapes adapted for a maxillary (upper) and mandibular (lower) denture.
Differential scanning calorimeter and powder X-ray diffraction results indicated that the crystallinity of both APIs was changed to amorphous phase after hot-melt extrusion. The ADA system, containing blends of HPC and PEO, enhanced the effectiveness of the antimicrobials a maximum of fivefold toward the inhibition of cell adherence of Candida albicans to mammalian cells/Vero cells. Remarkably, a combination of the two polymers without drug also demonstrated a 38% decrease in cell adhesion to the fungi due to the viscosity and the flexibility of the polymers. Drug-release profiles indicated that both drug concentrations were above the minimum inhibitory concentration (MIC) for C. albicans within 10 min and was maintained for over 10 h. In addition, based on the IC50 and MIC values, it was observed that the antifungal activities of both drugs were increased significantly in the ADA systems.
Based on these findings, the ADA system may be used for primary, prophylaxis or adjunct treatment of oral or pharyngeal candidiasis via controlled release of the antifungal agent from the polymer matrix.
本研究的总体目标是制备一种稳定的热熔挤出“抗真菌义齿粘附膜”(ADA)系统,用于治疗口腔念珠菌病。
使用实验室规模的双螺杆热熔挤出机,挤出含有羟丙基纤维素(HPC)和/或聚环氧乙烷(PEO)以及克霉唑(10%)或制霉菌素(10%)的ADA系统。收集含抗真菌剂的膜卷,随后冲切成适合上颌(上)和下颌(下)义齿的形状。
差示扫描量热法和粉末X射线衍射结果表明,两种活性药物成分(APIs)在热熔挤出后结晶度转变为非晶相。含有HPC和PEO混合物的ADA系统,对白色念珠菌与哺乳动物细胞/非洲绿猴肾细胞(Vero细胞)的细胞粘附抑制效果增强了最多五倍。值得注意的是,两种聚合物无药物的组合,由于聚合物的粘度和柔韧性,也使真菌细胞粘附减少了38%。药物释放曲线表明,两种药物浓度在10分钟内均高于白色念珠菌的最低抑菌浓度(MIC),并维持超过10小时。此外,基于半数抑制浓度(IC50)和最低抑菌浓度(MIC)值,观察到两种药物在ADA系统中的抗真菌活性均显著增加。
基于这些发现,ADA系统可通过从聚合物基质中控制释放抗真菌剂,用于口腔或咽部念珠菌病的主要、预防或辅助治疗。